bioRxivPhysiologyPreprint
Workload-induced changes to cell state contribute to β-cell failure in diabetes
Somesh SaiiD, Fenfen Liu, Austin R. Harrington, Han ZhuiD, Ibrahim Omar, Chun ZengiD, Medhavi Mallick, Yinghui Sui, Maike SanderiD, Matthew WorthamiD
Abstract
Insufficient insulin secretion relative to insulin demand is a key feature of type 2 diabetes (T2D). While the defects of insulin-producing {beta}-cells in T2D are well defined, little is known about how {beta}-cells progress from the functionally normal state to the decompensated state during the natural history of this disease. Here, we provide evidence that workload-induced {beta}-cell overstimulation precipitates {beta}-cell failure in T2D. We employ scRNA-seq to define workload-induced changes to {beta}-cell transcriptional states, identifying a novel compensating state that is distinct from the stressed state of decompensated {beta}-cells. We demonstrate a key role for the chromatin-modifying enzyme Lysine-specific demethylase 1 (Lsd1) in restraining workload-induced {beta}-cell state transitions, indicating epigenomic control of {beta}-cell state. Experimental manipulations that promote the compensating state accelerate {beta}-cell failure in mouse models of diabetes. Altogether, these findings show that the compensatory response of the {beta}-cell to increased workload becomes maladaptive over time and contributes to the pathogenesis of T2D.
- organism: mouse
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- AFF3 and BACH2 are master regulators of metabolic inflexibility, β/α-cell transition, and dedifferentiation in type 2 diabetes
J. Son, H. Ding, … A. Califano·bioRxiv·Sep 12, 2019
- Lipotoxicity Induces Beta Cell Small Extracellular Vesicle-mediated Beta Cell Dysfunction
Abhishek Roy, Alexandra Hoff, … Naureen Javeed·bioRxiv·Jul 19, 2024
- SGLT2 inhibitors therapy protects glucotoxicity-induced β-cell failure in a mouse model of human KATP-induced diabetes trough mitigation of oxidative and ER stress
Z. A. Shyr, Z. Yan, … M. S. Remedi·bioRxiv·Sep 17, 2021
- Heterogenous impairment of α-cell function in type 2 diabetes is linked to cell maturation state
X.-Q. Dai, J. Camunas-Soler, … P. E. MacDonald·bioRxiv·Apr 8, 2021
- Diabetes-associated MYT1 and MYT3 regulate human beta-cell insulin secretion and survival via other diabetes-risk genes
Ruiying Hu, Nala Hamilton, … Guoqiang Gu·DiabetologiaPeer-reviewed·Jun 5, 2026
- Compromised beta-cell identity in type 2 diabetes
Pritha Dutta, Nadège Merabet, … Peter M. A. Sloot·bioRxiv·Mar 20, 2023